@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:192180_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Péptidos endógenos presentes en la mayoría de los fluidos corporales. Ciertas enzimas los convierten en cininas activas que intervienen en la inflamación, la coagulación sanguínea y reacciones del complemento, entre otros. Pertenecen a la superfamilia de las cistatinas."@es, "Endogenous peptides present in most body fluids. Certain enzymes convert them to active kinins which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily."@en ;
  dc:source "Taken in part from: Medical Subject Headings 2018" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:192180
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2012-10-03"^^xsd:date ;
  dc:modified "2018-11-14"^^xsd:date ;
  skos:altLabel "T-kininogen"@en, "thiostatin"@en ;
  skos:broader nalt:192170 ;
  skos:definition nalt:192180_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "quininógenos"@es, "kininogens"@en ;
  skos:related nalt:10264 ;
  ns0:marc001 "88140" .

nalt:192170
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:192180 ;
  skos:prefLabel "cistatinas"@es, "cystatins"@en .

nalt:10264
  a ns0:Topic, skos:Concept ;
  skos:prefLabel "coagulación sanguínea"@es, "blood coagulation"@en ;
  skos:related nalt:192180 .